Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitor
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitor
Authors
Keywords
-
Journal
Science Advances
Volume 5, Issue 5, Pages eaav3660
Publisher
American Association for the Advancement of Science (AAAS)
Online
2019-05-23
DOI
10.1126/sciadv.aav3660
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of novel furanone derivatives as potent Cdc7 kinase inhibitors
- (2017) Takayuki Irie et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- ATR kinase inhibition induces unscheduled origin firing through a Cdc7-dependent association between GINS and And-1
- (2017) Tatiana Moiseeva et al. Nature Communications
- DNA replication licensing factor Cdc6 and Plk4 kinase antagonistically regulate centrosome duplication via Sas-6
- (2017) Xiaowei Xu et al. Nature Communications
- Increased global transcription activity as a mechanism of replication stress in cancer
- (2016) Panagiotis Kotsantis et al. Nature Communications
- Exploiting replicative stress to treat cancer
- (2015) Matthias Dobbelstein et al. NATURE REVIEWS DRUG DISCOVERY
- Aneuploidy generates proteotoxic stress and DNA damage concurrently with p53-mediated post-mitotic apoptosis in SAC-impaired cells
- (2015) Akihiro Ohashi et al. Nature Communications
- A Novel Time-Dependent CENP-E Inhibitor with Potent Antitumor Activity
- (2015) Akihiro Ohashi et al. PLoS One
- Regulation and roles of Cdc7 kinase under replication stress
- (2014) Masayuki Yamada et al. CELL CYCLE
- Synthesis and structure–activity relationship of trisubstituted thiazoles as Cdc7 kinase inhibitors
- (2014) Andreas Reichelt et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A Novel CDK9 Inhibitor Shows Potent Antitumor Efficacy in Preclinical Hematologic Tumor Models
- (2014) T. Yin et al. MOLECULAR CANCER THERAPEUTICS
- The optimization of aminooxadiazoles as orally active inhibitors of Cdc7
- (2013) Paul E. Harrington et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The causes and consequences of genetic heterogeneity in cancer evolution
- (2013) Rebecca A. Burrell et al. NATURE
- Causes and consequences of replication stress
- (2013) Michelle K. Zeman et al. NATURE CELL BIOLOGY
- Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity
- (2013) F. Kopper et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of XL413, a potent and selective CDC7 inhibitor
- (2012) Elena S. Koltun et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Meier-Gorlin syndrome mutations disrupt an Orc1 CDK inhibitory domain and cause centrosome reduplication
- (2012) M. Hossain et al. GENES & DEVELOPMENT
- Optimized Fast and Sensitive Acquisition Methods for Shotgun Proteomics on a Quadrupole Orbitrap Mass Spectrometer
- (2012) Christian D. Kelstrup et al. JOURNAL OF PROTEOME RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
- (2011) Philip M Reaper et al. Nature Chemical Biology
- Identifying differentially regulated subnetworks from phosphoproteomic data
- (2010) Martin Klammer et al. BMC BIOINFORMATICS
- Targeting Cell Division Cycle 7 Kinase: A New Approach for Cancer Therapy
- (2010) A. Montagnoli et al. CLINICAL CANCER RESEARCH
- The cyclin A centrosomal localization sequence recruits MCM5 and Orc1 to regulate centrosome reduplication
- (2010) R. L. Ferguson et al. JOURNAL OF CELL SCIENCE
- Chk1 promotes replication fork progression by controlling replication initiation
- (2010) E. Petermann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cdc7 Kinase Is a Predictor of Survival and a Novel Therapeutic Target in Epithelial Ovarian Carcinoma
- (2009) A. A. Kulkarni et al. CLINICAL CANCER RESEARCH
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- Orc1 Controls Centriole and Centrosome Copy Number in Human Cells
- (2009) A. S. Hemerly et al. SCIENCE
- Geminin is partially localized to the centrosome and plays a role in proper centrosome duplication
- (2008) Fei Lu et al. BIOLOGY OF THE CELL
- Cyclin E-dependent localization of MCM5 regulates centrosome duplication
- (2008) R. L. Ferguson et al. JOURNAL OF CELL SCIENCE
- Kinase-Selective Enrichment Enables Quantitative Phosphoproteomics of the Kinome across the Cell Cycle
- (2008) Henrik Daub et al. MOLECULAR CELL
- A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity
- (2008) Alessia Montagnoli et al. Nature Chemical Biology
- The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry
- (2008) Judit Villén et al. Nature Protocols
- An Oncogene-Induced DNA Damage Model for Cancer Development
- (2008) T. D. Halazonetis et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now